Back to News
Market Impact: 0.25

RIVN Quantitative Stock Analysis

RIVNNDAQ
Company FundamentalsAnalyst InsightsAutomotive & EVCorporate Earnings
RIVN Quantitative Stock Analysis

Validea's Benjamin Graham Value Investor model assigns Rivian Automotive Inc. (RIVN) a 57% rating, signaling it does not meet the criteria for strong interest under this deep value methodology. Despite passing on sales and debt metrics, RIVN fails key valuation (P/E, Price/Book) and long-term earnings growth tests, indicating it does not align with a traditional value investment profile.

Analysis

Rivian Automotive Inc. (RIVN) fundamentally fails to align with the principles of a classic deep value investment, according to a Validea analysis based on Benjamin Graham's model. The company received a score of 57%, which is significantly below the 80% threshold that indicates model interest. While RIVN exhibits balance sheet strength by passing criteria for its current ratio and maintaining low long-term debt relative to net current assets, it fails on the three core tenets of the Graham value strategy. Specifically, the analysis flags its lack of long-term EPS growth and its unfavorable valuation, as reflected by its failure on both the Price-to-Earnings (P/E) and Price-to-Book (P/B) ratio tests. This outcome is consistent with RIVN's classification as a large-cap growth stock, whose financial profile inherently conflicts with a methodology that prioritizes low multiples and a history of stable earnings, a conclusion supported by the negative per-ticker sentiment score of -0.5.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.30

Ticker Sentiment

NDAQ0.00
RIVN-0.50

Key Decisions for Investors

  • Strict value investors following a Graham-style methodology should view RIVN unfavorably, as it fails critical valuation and long-term earnings growth tests despite a healthy balance sheet.
  • Growth-oriented investors may find the strong sales and solid liquidity metrics encouraging, but must be willing to accept the high valuation multiples and the absence of proven, long-term profitability.
  • Given the stark contrast between its balance sheet health and its valuation/profitability metrics, investors should monitor upcoming earnings announcements for any improvement in the EPS growth trajectory, which is a key factor holding back its value score.